{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:33:33Z","timestamp":1786707213964,"version":"build-2736575974"},"reference-count":87,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p>Host cell proteins (HCPs) are major process\u2010related impurities in biopharmaceutical manufacturing, imposing metabolic burden on production hosts and complicating downstream purification, thereby impacting cost, product stability, and patient safety. Here, we engineered Chinese hamster ovary (CHO) cells toward a streamlined production chassis through multiplex CRISPR\u2010mediated knockout of abundant and difficult\u2010to\u2010remove HCPs. Proteomic profiling across multiple clones, products, and downstream purification steps identified a core set of highly abundant proteins that contributed disproportionately to total released HCP mass and showed limited removal by standard purification processes. Screening of 62 candidate genes using pooled and single\u2010cell knockout approaches identified targets compatible with cell growth and productivity, yielding 36 validated candidates suitable for host\u2010cell streamlining. Multiplex editing of selected targets achieved approximately 57\u201385% reduction in released HCP levels, depending on configuration, without compromising growth, viability, or productivity in fed\u2010batch cultures. The resulting cell lines maintained bioprocess performance while substantially lowering impurity load. Together, this work demonstrates a scalable, proteomics\u2010guided strategy for rational host\u2010cell engineering that enables upstream reduction of persistent impurities and supports cleaner, safer, and more cost\u2010efficient biopharmaceutical manufacturing.<\/jats:p>","DOI":"10.3389\/fbioe.2026.1750646","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:32:58Z","timestamp":1769761978000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Towards a cleaner CHO chassis: systematic knockout of host cell proteins for efficient biopharmaceutical manufacturing"],"prefix":"10.3389","volume":"14","author":[{"given":"Jannis Peter","family":"Marzluf","sequence":"first","affiliation":[{"name":"Corporate Research, Sartorius Stedim Cellca GmbH","place":["Ulm, Germany"]},{"name":"Department of Gene Therapy, University of Ulm","place":["Ulm, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Klein","sequence":"additional","affiliation":[{"name":"Corporate Research, Sartorius Stedim Cellca GmbH","place":["Ulm, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Kirchmeier","sequence":"additional","affiliation":[{"name":"Corporate Research, Sartorius Stedim Cellca GmbH","place":["Ulm, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"St\u00e4rk","sequence":"additional","affiliation":[{"name":"Corporate Research, Sartorius Stedim Cellca GmbH","place":["Ulm, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ziegner","sequence":"additional","affiliation":[{"name":"Corporate Research, Sartorius Stedim Cellca GmbH","place":["Ulm, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Gehrung","sequence":"additional","affiliation":[{"name":"Corporate Research, Sartorius Stedim Cellca GmbH","place":["Ulm, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Rauh","sequence":"additional","affiliation":[{"name":"Corporate Research, Sartorius Stedim Cellca GmbH","place":["Ulm, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merle","family":"Rattay","sequence":"additional","affiliation":[{"name":"Corporate Research, Sartorius Stedim Cellca GmbH","place":["Ulm, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Zehe","sequence":"additional","affiliation":[{"name":"Corporate Research, Sartorius Stedim Cellca GmbH","place":["Ulm, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Cathrin","family":"Leroux","sequence":"additional","affiliation":[{"name":"Corporate Research, Sartorius Stedim Cellca GmbH","place":["Ulm, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00253-024-13266-4","article-title":"CHO cell engineering via targeted integration of circular miR-21 decoy using CRISPR\/RMCE hybrid system","volume":"108","author":"Adibzadeh","year":"2024","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/bit.10096","article-title":"Decoupling cell growth and product formation in Chinese hamster ovary cells through metabolic control","volume":"76","author":"Altamirano","year":"2001","journal-title":"Biotechnol. Bioeng."},{"key":"B3","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/bit.28329","article-title":"CRISPR-Interceded CHO cell line development approaches","volume":"120","author":"Amiri","year":"2023","journal-title":"Biotechnol. Bioeng."},{"key":"B4","doi-asserted-by":"publisher","first-page":"10682","DOI":"10.3390\/ijms262110682","article-title":"Efficient delivery of CRISPR-Cas9 RNP complexes with cyclodextrin-based nanosponges for enhanced genome editing: TILD-CRISPR integration","volume":"26","author":"Amiri","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/bit.25628","article-title":"The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control","volume":"112","author":"Bracewell","year":"2015","journal-title":"Biotechnol. Bioengineering"},{"key":"B6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12896-021-00704-8","article-title":"Mapping the molecular basis for growth related phenotypes in industrial producer CHO cell lines using differential proteomic analysis","volume":"21","author":"Bryan","year":"2021","journal-title":"BMC Biotechnol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e3212","DOI":"10.1002\/btpr.3212","article-title":"A ribonucleoprotein-based decaplex CRISPR\/Cas9 knockout strategy for CHO host engineering","volume":"38","author":"Carver","year":"2022","journal-title":"Biotechnol. Progress"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/bit.26237","article-title":"Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations","volume":"114","author":"Chiu","year":"2017","journal-title":"Biotechnol. Bioeng."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1093\/nar\/gky092","article-title":"UniProt: the universal protein knowledgebase","volume":"46","author":"Consortium","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1002\/bit.27857","article-title":"Targeted CHO cell engineering approaches can reduce HCP-Related enzymatic degradation and improve mAb product quality","volume":"118","author":"Dovgan","year":"2021","journal-title":"Biotechnol. Bioeng."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.str.2012.03.021","article-title":"Structural and functional analysis of HtrA1 and its subdomains","volume":"20","author":"Eigenbrot","year":"2012","journal-title":"Structure"},{"key":"B13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1208\/s12248-016-9998-7","article-title":"Specific immune response to phospholipase B-Like 2 protein, a host cell impurity in lebrikizumab clinical material","volume":"19","author":"Fischer","year":"2017","journal-title":"AAPS J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.biologicals.2016.01.001","article-title":"Industry view on the relative importance of \u201cclonality\u201d of biopharmaceutical-producing cell lines","volume":"44","author":"Frye","year":"2016","journal-title":"Biologicals"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e2820","DOI":"10.1002\/btpr.2820","article-title":"Anxa2-and Ctsd-knockout CHO cell lines to diminish the risk of contamination with host cell proteins","volume":"35","author":"Fukuda","year":"2019","journal-title":"Biotechnol. Progress"},{"key":"B16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00253-024-13008-6","article-title":"Recombinant therapeutic proteins degradation and overcoming strategies in CHO cells","volume":"108","author":"Geng","year":"2024","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1002\/bit.26437","article-title":"Cascading effect in bioprocessing\u2014The impact of mild hypothermia on CHO cell behavior and host cell protein composition","volume":"114","author":"Goey","year":"2017","journal-title":"Biotechnol. Bioeng."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.biotechadv.2018.03.021","article-title":"Host cell protein removal from biopharmaceutical preparations: towards the implementation of quality by design","volume":"36","author":"Goey","year":"2018","journal-title":"Biotechnol. Advances"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/biot.201500027","article-title":"One-step generation of triple knockout CHO cell lines using CRISPR\/Cas9 and fluorescent enrichment","volume":"10","author":"Grav","year":"2015","journal-title":"Biotechnol. J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"8836","DOI":"10.1016\/j.chroma.2011.09.008","article-title":"Separation science is the key to successful biopharmaceuticals","volume":"1218","author":"Guiochon","year":"2011","journal-title":"J. Chromatography. A"},{"key":"B21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ymben.2019.11.008","article-title":"Knockout of sialidase and pro-apoptotic genes in Chinese hamster ovary cells enables the production of recombinant human erythropoietin in fed-batch cultures","volume":"57","author":"Ha","year":"2020","journal-title":"Metab. Eng."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1002\/bit.28128","article-title":"Comprehensive assessment of host cell protein expression after extended culture and bioreactor production of CHO cell lines","volume":"119","author":"Hamaker","year":"2022","journal-title":"Biotech and Bioeng."},{"key":"B23","doi-asserted-by":"publisher","first-page":"68044","DOI":"10.18632\/oncotarget.11172","article-title":"Peroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesis","volume":"7","author":"Han","year":"2016","journal-title":"Oncotarget"},{"key":"B24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biotechadv.2016.11.008","article-title":"Improving the secretory capacity of Chinese hamster ovary cells by ectopic expression of effector genes: lessons learned and future directions","volume":"35","author":"Hansen","year":"2017","journal-title":"Biotechnol. Advances"},{"key":"B25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","article-title":"Array programming with NumPy","volume":"585","author":"Harris","year":"2020","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"W375","DOI":"10.1093\/nar\/gkh378","article-title":"PrediSi: prediction of signal peptides and their cleavage positions","volume":"32","author":"Hiller","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.copbio.2014.06.017","article-title":"Measurement and control of host cell proteins (HCPs) in CHO cell bioprocesses","volume":"30","author":"Hogwood","year":"2014","journal-title":"Curr. Opin. Biotechnol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-Guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/mcse.2007.55","article-title":"Matplotlib: a 2D graphics environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput. Science and Engineering"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1126\/science.1176009","article-title":"The extracellular matrix: not just pretty fibrils","volume":"326","author":"Hynes","year":"2009","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2016.01.054","article-title":"ALDOA functions as an oncogene in the highly metastatic pancreatic cancer","volume":"374","author":"Ji","year":"2016","journal-title":"Cancer Lett."},{"key":"B32","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1074\/jbc.RA119.012312","article-title":"Perturbation of phosphoglycerate kinase 1 (PGK1) only marginally affects glycolysis in cancer cells","volume":"295","author":"Jin","year":"2020","journal-title":"J. Biol. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1002\/bit.27808","article-title":"High-risk\u2019 host cell proteins (HCPs): a multi-company collaborative view","volume":"118","author":"Jones","year":"2021","journal-title":"Biotechnol. Bioeng."},{"key":"B34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/978-1-61779-433-9_32","article-title":"Engineering the chaperone network of CHO cells for optimal recombinant protein production and authenticity","volume":"824","author":"Joss\u00e9","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"108115","DOI":"10.1016\/j.biotechadv.2023.108115","article-title":"Improving recombinant protein production in CHO cells using the CRISPR-cas system","volume":"64","author":"Kalkan","year":"2023","journal-title":"Biotechnol. Adv."},{"key":"B36","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ymben.2021.03.017","article-title":"A metabolic CRISPR-Cas9 screen in Chinese hamster ovary cells identifies glutamine-sensitive genes","volume":"66","author":"Karottki","year":"2021","journal-title":"Metab. Eng."},{"key":"B37","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00253-011-3758-5","article-title":"CHO cells in biotechnology for production of recombinant proteins: current state and further potential","volume":"93","author":"Kim","year":"2012","journal-title":"Appl. Microbiology Biotechnology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/bit.28611","article-title":"Genome-wide CRISPR\/Cas9 knockout screening to mitigate cell growth inhibition induced by histone deacetylase inhibitors in recombinant CHO cells","volume":"121","author":"Kim","year":"2024","journal-title":"Biotechnol. Bioeng."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1002\/bit.27811","article-title":"Unveiling the CHO surfaceome: identification of cell surface proteins reveals cell aggregation-relevant mechanisms","volume":"118","author":"Klingler","year":"2021","journal-title":"Biotechnol. Bioengineering"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15866-w","article-title":"Multiplex secretome engineering enhances recombinant protein production and purity","volume":"11","author":"Kol","year":"2020","journal-title":"Nat. Commun."},{"key":"B41","article-title":"ComplexUpset: create complex UpSet plots using Ggplot2 components","author":"Krassowski","year":"2023"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1021\/acs.jproteome.5b00588","article-title":"Elucidation of the CHO super-ome (CHO-SO) by proteoinformatics","volume":"14","author":"Kumar","year":"2015","journal-title":"J. Proteome Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e3471","DOI":"10.1002\/btpr.3471","article-title":"Strategies to improve CHO cell culture performance: targeted deletion of amino acid catabolism and apoptosis genes paired with growth inhibitor supplementation","volume":"40","author":"Lam","year":"2024","journal-title":"Biotechnol. Prog."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1002\/bit.26731","article-title":"Degradation of recombinant proteins by Chinese hamster ovary host cell proteases is prevented by matriptase-1 knockout","volume":"115","author":"Laux","year":"2018","journal-title":"Biotechnol. Bioeng."},{"key":"B45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pep.2017.04.006","article-title":"Effective strategies for host cell protein clearance in downstream processing of monoclonal antibodies and Fc-fusion proteins","volume":"134","author":"Li","year":"2017","journal-title":"Protein Expr. Purif."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e2000267","DOI":"10.1002\/biot.202000267","article-title":"Improving antibody production in stably transfected CHO cells by CRISPR-Cas9-Mediated inactivation of genes identified in a large-scale screen with Chinese hamster-specific siRNAs","volume":"16","author":"Lin","year":"2021","journal-title":"Biotechnol. J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.3390\/ijms25094816","article-title":"CRISPR screen identifies the RNA-binding protein Eef1a1 as a key regulator of myogenesis","volume":"25","author":"Liu","year":"2024","journal-title":"IJMS"},{"key":"B48","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.1007\/s00253-018-9070-x","article-title":"Inactivation of deubiquitinase CYLD enhances therapeutic antibody production in Chinese hamster ovary cells","volume":"102","author":"Lu","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/bit.28062","article-title":"Modeling apoptosis resistance in CHO cells with CRISPR\u2010mediated knockouts of Bak1, bax, and bok","volume":"119","author":"MacDonald","year":"2022","journal-title":"Biotechnol. Bioeng."},{"key":"B50","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12033-024-01060-6","article-title":"From efficiency to yield: exploring recent advances in CHO cell line development for monoclonal antibodies","volume":"67","author":"Majumdar","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"B51","first-page":"113847","article-title":"Genetic drivers of Chinese hamster ovary cell proliferation revealed by functional genomics","volume-title":"iScience","author":"Marzluf","year":""},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/biot.70033","article-title":"Utilizing stable gene-edited knockout pools for genetic screening and engineering in Chinese hamster ovary cells","author":"Marzluf","year":"","journal-title":"Biotechnol. J"},{"key":"B53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.25080\/Majora-92bf1922-00a","article-title":"Data structures for statistical computing in python","volume":"445","author":"McKinney","year":"2010","journal-title":"Proc. 9th Python Sci. Conf."},{"key":"B54","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.cellsig.2016.01.005","article-title":"Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy","volume":"28","author":"Moore","year":"2016","journal-title":"Cell. Signal."},{"key":"B55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s41021-021-00211-4","article-title":"PRDX1 is essential for the viability and maintenance of reactive oxygen species in chicken DT40","volume":"43","author":"Moriwaki","year":"2021","journal-title":"Genes Environ."},{"key":"B56","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13059-017-1237-8","article-title":"CRISPR\/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion","volume":"18","author":"Mou","year":"2017","journal-title":"Genome Biol."},{"key":"B57","unstructured":"NIST monoclonal antibody reference material 8671\n          \n          \n          2016"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e888","DOI":"10.1038\/cddis.2013.410","article-title":"Cyclophilin A: a key player for human disease","volume":"4","author":"Nigro","year":"2013","journal-title":"Cell. Death and Disease"},{"key":"B59","doi-asserted-by":"publisher","first-page":"44246","DOI":"10.1038\/srep44246","article-title":"Proteomic analysis of host cell protein dynamics in the culture supernatants of antibody-producing CHO cells","volume":"7","author":"Park","year":"2017","journal-title":"Sci. Reports"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1182\/blood-2008-03-144600","article-title":"Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells","volume":"112","author":"Peipp","year":"2008","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1700499","DOI":"10.1002\/biot.201700499","article-title":"Impact of CHO metabolism on cell growth and protein production: an overview of toxic and inhibiting metabolites and nutrients","volume":"13","author":"Pereira","year":"2018","journal-title":"Biotechnol. J."},{"key":"B62","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.bbrc.2011.06.165","article-title":"Accelerated cellular senescence phenotype of GAPDH-Depleted human lung carcinoma cells","volume":"411","author":"Phadke","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e8432","DOI":"10.1371\/journal.pone.0008432","article-title":"Intraclonal protein expression heterogeneity in recombinant CHO cells","volume":"4","author":"Pilbrough","year":"2009","journal-title":"PloS One"},{"key":"B64","article-title":"Python language reference","year":"2024"},{"key":"B65","volume-title":"R: a language and environment for statistical computing","year":"2024"},{"key":"B66","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/bit.260410204","article-title":"Cell\u2013cell adhesion and aggregation: influence on the growth behavior of CHO cells","volume":"41","author":"Renner","year":"1993","journal-title":"Biotechnol. Bioeng."},{"key":"B67","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.nbt.2024.10.003","article-title":"Beyond viability: advancing CHO cell culture process strategies to modulate host cell protein levels","volume":"84","author":"Sahoo","year":"2024","journal-title":"New Biotechnol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13059-017-1240-0","article-title":"Unexpected consequences: exon skipping caused by CRISPR-Generated mutations","volume":"18","author":"Sharpe","year":"2017","journal-title":"Genome Biol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.tibtech.2010.02.001","article-title":"Recent advances in large-scale production of monoclonal antibodies and related proteins","volume":"28","author":"Shukla","year":"2010","journal-title":"Trends Biotechnol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/s41592-019-0614-5","article-title":"Biological plasticity rescues target activity in CRISPR knock outs","volume":"16","author":"Smits","year":"2019","journal-title":"Nat. Methods"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.3390\/ijms24043230","article-title":"Evidence and metabolic implications for a new non-canonical role of Cu-Zn superoxide dismutase","volume":"24","author":"Sun","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e3228","DOI":"10.1002\/btpr.3228","article-title":"Bax and bak knockout apoptosis-resistant Chinese hamster ovary cell lines significantly improve culture viability and titer in intensified fed-batch culture process","volume":"38","author":"Tang","year":"2022","journal-title":"Biotechnol. Prog."},{"key":"B73","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ddtec.2021.02.003","article-title":"Recent advances in CHO cell line development for recombinant protein production","volume":"38","author":"Tihanyi","year":"2020","journal-title":"Drug Discov. Today Technol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1038\/s41467-019-12028-5","article-title":"CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation","volume":"10","author":"Tuladhar","year":"2019","journal-title":"Nat. Commun."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1002\/bit.25515","article-title":"Expression of difficult-to-remove host cell protein impurities during extended Chinese hamster ovary cell culture and their impact on continuous bioprocessing","volume":"112","author":"Valente","year":"2015","journal-title":"Biotechnol. Bioeng."},{"key":"B76","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.copbio.2018.01.004","article-title":"Applications of proteomic methods for CHO host cell protein characterization in biopharmaceutical manufacturing","volume":"53","author":"Valente","year":"2018","journal-title":"Curr. Opinion Biotechnology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/cm.21647","article-title":"Time for rethinking the different \u03b2-actin transgenic mouse models?","volume":"77","author":"Vanslembrouck","year":"2020","journal-title":"Cytoskeleton"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e1700495","DOI":"10.1002\/biot.201700495","article-title":"Changes in chromosome counts and patterns in CHO cell lines upon generation of recombinant cell lines and subcloning","volume":"13","author":"Vcelar","year":"2018","journal-title":"Biotechnol. Journal"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/s41587-022-01582-x","article-title":"Biopharmaceutical benchmarks 2022","volume":"40","author":"Walsh","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/bit.22304","article-title":"Host cell proteins in biologics development: identification, quantitation and risk assessment","volume":"103","author":"Wang","year":"2009","journal-title":"Biotechnol. Bioengineering"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.tibtech.2025.04.016","article-title":"Without a trace: multiple knockout of CHO host cell hydrolases to prevent polysorbate degradation in biologics","volume":"43","author":"Wei\u00df","year":"2025","journal-title":"Trends Biotechnol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0968-0004(99)01534-0","article-title":"Clusterin is a secreted Mammalian chaperone","volume":"25","author":"Wilson","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"100062","DOI":"10.1016\/j.crmeth.2021.100062","article-title":"An optimized genome-wide, virus-free CRISPR screen for Mammalian cells","volume":"1","author":"Xiong","year":"2021","journal-title":"Cell. Rep. Methods"},{"key":"B84","doi-asserted-by":"publisher","first-page":"E75","DOI":"10.1038\/ncb0402-e75","article-title":"Integrin regulation of growth factor receptors","volume":"4","author":"Yamada","year":"2002","journal-title":"Nat. Cell. Biol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/bit.20151","article-title":"Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody\u2010dependent cellular cytotoxicity","volume":"87","author":"Yamane\u2010Ohnuki","year":"2004","journal-title":"Biotech and Bioeng."},{"key":"B86","doi-asserted-by":"publisher","first-page":"107195","DOI":"10.1016\/j.phrs.2024.107195","article-title":"The eEF1A protein in cancer: clinical significance, oncogenic mechanisms, and targeted therapeutic strategies","volume":"204","author":"Zhang","year":"2024","journal-title":"Pharmacol. Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/bit.25327","article-title":"Host cell protein testing by ELISAs and the use of orthogonal methods","volume":"111","author":"Zhu-Shimoni","year":"2014","journal-title":"Biotechnol. Bioeng."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2026.1750646\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:33:01Z","timestamp":1769761981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2026.1750646\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":87,"alternative-id":["10.3389\/fbioe.2026.1750646"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2026.1750646","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"article-number":"1750646"}}